Lack of knowledge about the patient’s brain activity has often made it difficult to optimize and adjust medicine use in the treatment of epilepsy, but it has now become possible with the new system that is available commercially in the market.
According to the World Health Organization
, epilepsy is the most common serious brain disorder worldwide with no age, racial, social class, national or geographic boundaries. More than 65 million people around the world live with epilepsy, and 30 to 40 percent of people with epilepsy are not able to control their seizures with available treatments. The initial target group for UNEEG 24/7 is the 30% of people who are most affected by epilepsy and who are not responding sufficiently to conventional medical treatment.
The invention is the first of its kind in the world and consists of two elements: a discreet implant, inserted under the skin behind the patient’s ear, and a wireless mobile EEG recorder which constantly monitors the brain’s electrical activity, thus recording epileptic seizures. Everything is supported by an app and advanced software. The implant is powered by induction and can therefore remain under the skin, as no battery is necessary. The implant is inserted during a 15-minute outpatient operation and causes no serious side effects to the patient.
The implant has so far been approved for adults, but we aim to have it approved for children, too.